Ironwood Pharmaceuticals
IRWD
IRWD
254 hedge funds and large institutions have $1.74B invested in Ironwood Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 107 increasing their positions, 79 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
254
Holders Change
+4
Holders Change %
+1.6%
% of All Funds
4.07%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
27
Increased
107
Reduced
79
Closed
21
Calls
$412K
Puts
$30K
Net Calls
+$382K
Net Calls Change
-$1.19M
Top Buyers
| 1 |
Jane Street
New York
|
$20.3M |
| 2 |
Morgan Stanley
New York
|
$40M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
$10M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
$48.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$12.7M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$65M |
| 2 |
Millennium Management
New York
|
$14.5M |
| 3 |
Man Group
London,
United Kingdom
|
$14.6M |
| 4 |
JPMorgan Chase & Co
New York
|
$6.68M |
| 5 |
State Street
Boston,
Massachusetts
|
$110M |
